Professor Dipak Kotecha MBChB PhD(Clinical Cardiology) PCAP MSc(Clinical Trials) MRCP FHEA FESC

Dipak Kotecha

Institute of Cardiovascular Sciences
Professor of Cardiology

Contact details

Telephone
+44 (0) 121 371 8122
Telephone (2)
Clinical Secretary +44 (0) 121 371 4399
Email
d.kotecha@bham.ac.uk
View my research portal
Address
Institute of Cardiovascular Sciences
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Dipak Kotecha is a Professor of Cardiology at the University of Birmingham, a Consultant Cardiologist specialising in cardiac imaging, and has completed a prestigious National Institute for Health Research (NIHR) Fellowship. He works extensively across the European Society of Cardiology (ESC) in education, trials and guidelines, and his research focuses on the interaction of heart failure and atrial fibrillation, supported by grants from the NIHR, British Heart Foundation and European Union.

Dipak collaborates widely, with interests in patient involvement, big data approaches, the application of artificial intelligence, and the use of novel technology such as mobile applications and wearable devices. He is passionate about innovative yet pragmatic trial design and healthcare-embedded approaches to improve patient care – this includes the RATE-AF trial (recently published in a top medical journal) and the soon-to-be-launched DaRe2THINK randomised controlled trial embedded in the National Health Service. Dipak was awarded the British Cardiovascular Society Michael Davies Medal in 2018 for his contribution to cardiovascular medicine.

Qualifications

  • Masters in Clinical Trials, MSc 2018 (Distinction); London School of Hygiene & Tropical Medicine, University of London
  • Postgraduate Certificate in Academic Practice, PCAP 2016 (Distinction); University of Birmingham
  • Fellow, FHEA 2015; Higher Education Academy
  • Fellow, FESC 2015; European Society of Cardiology
  • Cardiology accreditation, CCT 2014; General Medical Council
  • Doctorate, PhD 2010; Imperial College London
  • Member, MRCP 2004; Royal College of Physicians
  • Bachelor of Medicine/Surgery, MBChB 2000; University of Bristol

Biography

Dipak studied Medicine at the University of Bristol and trained as a junior doctor in the south-west of England. After gaining Membership of the Royal College of Physicians in 2004 he departed for Australia to gain further clinical and academic experience. He worked as a Cardiology Registrar in Melbourne for 2 years before starting his PhD studies. Registered at the world-leading National Heart & Lung Institute at Imperial College London, the PhD was an international collaborative project with the Royal Brompton Hospital in London and Monash University in Melbourne. Dipak worked with international leaders in their fields, including Professor Marcus Flather (now in Norwich) and the late Professors Philip Poole-Wilson and Henry Krum.

After completing his PhD, Dipak re-joined the NHS in 2009 and was a clinical trainee in Oxford, specialising in cardiac imaging. During this time he continued his academic work, leading to his appointment as a Clinical Lecturer here in Birmingham, and subsequently appointment as a Clinician Scientist and Consultant Cardiologist at the University Hospitals Birmingham NHS Trust and Sandwell & West Birmingham Hospitals NHS Trust. 

Dipak was awarded Fellowship of the European Society of Cardiology (ESC) for his work in the prevention and management of cardiovascular disease, and Fellowship of the Higher Education Academy for his teaching. In 2016, he commenced his NIHR Career Development Fellowship designed to improve patient wellbeing in those needing rate control for atrial fibrillation. His efforts were recognised in 2018 when he won the British Cardiovascular Society Michael Davies National Award for his early career contribution to cardiovascular medicine.

Dipak is an Honorary Fellow at Monash University in Melbourne (Australia), the University Medical Center in Utrecht (the Netherlands) and the Clinical Trial Service Unit and Epidemiological Studies Unit in Oxford (UK).

Teaching

  • MD / PhD students and research fellows in clinical and translational projects
  • Clinical teaching
  • International lectures on heart failure, atrial fibrillation, ‘Big Data’ and statistical methods

Postgraduate supervision

Dr Kotecha currently has openings for self-funded PhD students with the following attributes:

  • Medical doctors with cardiology experience
  • Skills in cardiac imaging (echocardiography, cardiac MRI)
  • Experience in IT, statistical analysis or database management
  • Motivated to produce high-impact clinical studies

Research

Heart rate control in atrial fibrillation (RATE-AF trial Birmingham)

Nine ‘hotline’ late-breaking presentations in major international conferences: 2018 [x2] HFA Congress Vienna; 2018 EHRA Congress Barcelona; 2017 [x2] ESC Congress Barcelona; 2017 HFA Congress Paris; 2015 [x2] ESC Congress London; and 2014 ESC Congress Barcelona.

Other activities

  • European Society of Cardiology (ESC) Guideline Task Force on Atrial Fibrillation 2014-2016, ESC Education Committee 2016-2018 & 2018-2020, ESC Congress Programme Committee 2018-2020, ESC STEEER-AF Cluster Randomised Trial Chief Investigator (2018-2020).
  • Frequent invitations as faculty for international meetings and conferences, including the European Society of Cardiology Congress, European Heart Rhythm Association, Heart Failure Association, British Cardiovascular Society, Royal College of Physicians of London and Physicians’ Academy for Cardiovascular Education (PACE) Foundation.
  • Lead chapter author for heart failure and atrial fibrillation; ESC Textbook of Cardiovascular Medicine 3rd edition.
  • Two patients awarded Patient Research Partner Scholarships to present NIHR-funded research at the International Society for Quality of Life Research (ISOQOL) conference, Dublin 2018.

Publications

Recent publications

Article

Bunting, K, O'Connor, K, Steeds, R & Kotecha, D 2021, 'Cardiac imaging to assess left ventricular systolic function in atrial fibrillation', The American Journal of cardiology, vol. 139, pp. 40-49. https://doi.org/10.1016/j.amjcard.2020.10.012

Fabritz, L, Crijns, HJGM, Guasch, E, Goette, A, Hausler, K, Kotecha, D, Lewalter, T, Meyer, CG, Potpara, TS, Rienstra, M, B Schnabel, R, Willems, S, Breithardt, G, Camm, AJ, Chan, A, Chua, WWL, De Melis, M, Dimopoulou, C, Dobrev, D, Easter, C, Eckardt, L, Haase, D, Hatem, S, Healey, JS, Heijman, J, Hohnloser, SH, Huebner, T, Saeed Ilyas, B, Isaacs, A, Kutschka, I, Leclercq, C, Lip, GYH, Marinelli, EA, Merino, JL, Mont, L, Nabauer, M, Oldgren, J, Pürerfellner, H, Ravens, U, Savelieva, I, Sinner, MF, Sitch, A, Smolnik, R, Steffel, J, Stein, K, Stoll, M, Svennberg, E, Thomas, D, Van Gelder, IC, Vardar, B, Wakili, R, Wieloch, M, Zeemering, S, Ziegler, P, Heidbuchel, H, Hindricks, G, Schotten, U & Kirchhof, P 2021, 'Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference', EP Europace, vol. 23, no. 3, pp. 329–344. https://doi.org/10.1093/europace/euaa279

Bunting, K, Gill, S, Sitch, A, Mehta, S, O'Connor, K, Lip, G, Kirchhof, P, Strauss , VY, Rahimi, K, Camm, AJ, Stanbury, M, Griffith, M, Townend, J, Gkoutos, G, Karwath, A, Steeds, R & Kotecha, D 2021, 'Improving the diagnosis of heart failure in patients with atrial fibrillation', Heart, vol. 107, no. 11, pp. 902-908. https://doi.org/10.1136/heartjnl-2020-318557

Karwath, A, Bunting, KV, Gill, SK, Tica, O, Pendleton, S, Aziz, F, Barsky, AD, Chernbumroong, S, Duan, J, Mobley, AR, Cardoso, VR, Slater, L, Williams, JA, Bruce, E, Wang, X, Flather, MD, Coats, AJS, Gkoutos, GV & Kotecha, D 2021, 'Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis', The Lancet, vol. 2021, pp. 1-9. https://doi.org/10.1016/s0140-6736(21)01638-x

Bunting, K, Stanbury, M, Tica, O & Kotecha, D 2021, 'Transforming clinical research by involving and empowering patients— the RATE-AF randomized trial: designed and managed with the support of patient and public representatives, the RATE-AF trial is the first head-to-head randomized trial of digoxin vs. beta-blockers in patients with atrial fibrillation and symptoms of heart failure ', European Heart Journal. https://doi.org/10.1093/eurheartj/ehab098

Ziff, O, Samra, M, Howard, J, Bromage, D, Ruschitzka, F, Francis, D & Kotecha, D 2020, 'Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment', BMC Medicine, vol. 18, no. 1, 103. https://doi.org/10.1186/s12916-020-01564-3

Rate Control Therapy Evaluation in Permanent 13 Atrial Fibrillation (RATE-AF) team, Kotecha, D, Bunting, K, Gill, S, Mehta, S, Stanbury, M, Jones, J, Haynes , S, Calvert, M, Deeks, J, Steeds, RP, Strauss , VY, Rahimi, K, Camm, AJ, Griffith, M, Lip, G, Townend, JN & Kirchhof, P 2020, 'Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial', JAMA The Journal of the American Medical Association, vol. 324, no. 24, pp. 2497-2508. https://doi.org/10.1001/jama.2020.23138

Jones, J, Stanbury, M, Haynes , S, Bunting, K, Lobban, T, Camm, AJ, Calvert, M & Kotecha, D 2020, 'Importance and assessment of quality of life in symptomatic permanent atrial fibrillation: Patient focus groups from the RATE-AF trial', Cardiology, vol. 145, no. 10, pp. 666-675. https://doi.org/10.1159/000511048

Kotecha, D & Castellá, M 2020, 'Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?', European Heart Journal, vol. 41, no. 5, pp. 652-654a. https://doi.org/10.1093/eurheartj/ehz412

Vijapurapu, R, Baig, S, Nordin, S, Augusto, J, Price, A, Wheeldon, NM, Lewis, N, Kozor, R, Kotecha, D, Hodson, J, Hughes, DA, Moon, JC, Geberhiwot, T & Steeds, R 2020, 'Longitudinal assessment of cardiac involvement in Fabry disease using cardiovascular magnetic resonance imaging', JACC: Cardiovascular Imaging, vol. 13, no. 8, pp. 1850-1852. https://doi.org/10.1016/j.jcmg.2020.03.004

Dretzke, J, Chuchu, N, Agarwal, R, Herd, C, Chua, WWL, Fabritz, L, Bayliss, S, Kotecha, D, Deeks, J, Kirchhof, P & Takwoingi, Y 2020, 'Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models', Europace, vol. 22, no. 5, pp. 748–760. https://doi.org/10.1093/europace/euaa041

Bunting, K, Van Gelder, IC & Kotecha, D 2020, 'STEEER-AF: a cluster-randomised education trial from the ESC: The STEEER-AF trial is designed by the European Society of Cardiology (ESC) to see if better education for healthcare professionals can improve how patients are treated and how AF is managed', European Heart Journal, vol. 41, no. 21, pp. 1952–1954. https://doi.org/10.1093/eurheartj/ehaa421

Bunting, KV, Steeds, RP, Slater, LT, Rogers, JK, Gkoutos, GV & Kotecha, D 2019, 'A practical guide to assess reproducibility of echocardiographic measurements', Journal of the American Society of Echocardiography, vol. 32, no. 12, pp. 1505-1515. https://doi.org/10.1016/j.echo.2019.08.015, https://doi.org/10.1016/j.echo.2019.08.015

Vijapurapu, R, Kozor, R, Hughes, DA, Woolfson, P, Jovanovic, A, Deegan, P, Rusk, R, Figtree, GA, Tchan, M, Whalley, D, Kotecha, D, Leyva-Leon, F, Moon, JC, Geberhiwot, T & Steeds, R 2019, 'A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice', Trials, vol. 20, 314. https://doi.org/10.1186/s13063-019-3425-1

Lueder, TGV, Atar, D, Agewall, S, Jensen, JK, Hopper, I, Kotecha, D, Mentz, R, Kim, MH & Serebruany, VL 2019, 'All-cause mortality and cardiovascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the Food and Drug Administration Adverse Event Reporting System', American Journal of Therapeutics, vol. 26, no. 6, pp. e671-e678. https://doi.org/10.1097/MJT.0000000000000883

View all publications in research portal